27 May 2013 | News | By BioSpectrum Bureau
Japan medtech firm Arkray signs $9.1 million research collaboration with A*Star's Institute of Bioengineering and Nanotechnology (IBN)
Singapore: Japan's technology company, Arkray is investing $9.1 million over a five-year period in a research venture and collaboration with A*Star's Institute of Bioengineering and Nanotechnology (IBN), Singapore.
Professor Jackie Y Ying, executive director, IBN, said that, "We are delighted to announce our partnership with Arkray, which has a long history of leadership in medical technology. IBN identifies with Arkay's vision of improving lives through scientific advancement and new technological discoveries."
Professor Ying added, "We are confident that our collaboration with Arkray will lead to new devices and advanced instruments for disease detection and monitoring."
Mr Takeshi Matsuda, president and CEO, Arkray said that, "ARKRAY is excited to embark on this new venture with IBN. We have chosen to set up our newest research center in Singapore because of IBN's distinguished knowledge and expertise in a wide variety of scientific fields, and we believe we can find a lot of opportunities to produce synergy with IBN through a long-term relationship."